期刊
RESPIRATORY CARE
卷 59, 期 9, 页码 1389-1397出版社
DAEDALUS ENTERPRISES INC
DOI: 10.4187/respcare.02941
关键词
Chronic obstructive pulmonary disease; mechanical ventilation; sleep quality; target volume; ventilation mode
资金
- Breas Medical
- Respironics
- ResMed Germany
- Weinmann
- Vivisol
- Heinen und Lowenstein
- Werner und Muller Medizintechnik
- SenTec AG
- Radiometer Medical Aps
- Keller Medical
- SenTec
- Vivisol Germany
- Sapio Life
- Bayer
- VitalAire
- ResMed
- Drager Medical
- Linde
- Covidien
- Magnet
- Siare
BACKGROUND: High-intensity noninvasive ventilation (HI-NIV) is the most effective means of improving several physiological and clinical parameters in subjects with chronic hypercapnic COPD. Whether the newer hybrid mode using target tidal volume noninvasive ventilation (target V-T NIV) provides additional benefits remains unclear. METHODS: Subjects with COPD successfully established on long-term HI-NIV were switched to target V-T NW. Optimal target V-T settings according to nocturnal transcutaneous P-CO2 measurements were achieved following a randomized crossover trial using 8 mL/kg ideal body weight and 110% of individual V-T during HI-MV, respectively. The following parameters were compared at the beginning of the trial while subjects were on HI-NW, and after 3 months on optimal target V-T NIV: sleep quality by polysomnography, overnight gas exchange, subjects' tolerance, overnight pneumotachygraphic measurements during NW, health-related quality of life (severe respiratory insufficiency questionnaire), exercise capacity (6-min walk test), and lung function. RESULTS: Ten of 14 subjects completed the study. There were no differences between HI-NIV and target V-T NIV in any of the above-mentioned parameters. Specifically, the mean overnight transcutaneous P-CO2, was equivalent under each form of ventilation (both 45 +/- 5 mm Hg, P = .75). CONCLUSIONS: Switching subjects from well-established HI-NIV to target V-T NIV shows no clinical benefits in chronic hypercapnic COPD. In particular, sleep quality, the control of nocturnal hypoventilation, daytime hypercapnia, overnight ventilation patterns, subjects' tolerance, health-related quality of life, lung function, and exercise capability were all similar in subjects who underwent HI-NIV and target V-T NW. Nevertheless, target V-T NW might offer some physiological advantages in breathing pattern and might be beneficial in some individual patients. (German Clinical Trials Register Iwww.drks.dej Registration DRKS00000450.)
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据